1. Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom
2. Department of Chemistry, Technical University of Munich, 85748 Garching, Germany
3. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, U.K.
4. Translational Medicine, Oncology R&D, Astra Zeneca, Cambridge CB4 0WG, United Kingdom
5. Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg, 35032 Marburg, Germany
6. Department of Pharmaceutical Biosciences, Medical Mass Spectrometry Imaging, Uppsala University, 751 24 Uppsala, Sweden
7. Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden
8. Bioscience, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom
9. Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom
10. Biologics Engineering, R&D, AstraZeneca, Cambridge CB12 6GH, United Kingdom
11. DMPK, Oncology R&D, AstraZeneca, Cambridge CB2 0RE, United Kingdom
12. Clinical IO group, Early Oncology, AstraZeneca, Cambridge CB12 6GH, United Kingdom
13. National Centre of Excellence in Mass Spectrometry Imaging, National Physical Laboratory, Teddington TW11 0LW, United Kingdom
14. Rosalind Franklin Institute, Didcot OX11 0QS, United Kingdom
15. Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom
16. Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom
17. Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, United Kingdom
18. Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom
19. Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, United Kingdom